Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-(4-bromophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl Decanoate
2. Impromen Decanoas
1. 75067-66-2
2. 4-(4-bromophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)piperidin-4-yl Decanoate
3. 73lg72m4lv
4. R-46541
5. Decanoic Acid,4-(4-bromophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinyl Ester
6. Bromperidol Decanoate (usan)
7. R-46,541
8. Bromperidol Decanoate [usan]
9. Decanoic Acid, 4-(4-bromophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl Ester
10. Unii-73lg72m4lv
11. Bromperidoldecanoat
12. Bromperidol Decanoate [usan:ban]
13. Einecs 278-065-1
14. [4-(4-bromophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl] Decanoate
15. Bromoperidol Decanoate
16. R 46541
17. Schembl121019
18. Chembl2106135
19. Dtxsid30226039
20. Bromperidol Decanoate [mart.]
21. 4-(4-bromophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl Decanoate
22. Bromperidol Decanoate [usp-rs]
23. Bromperidol Decanoate [who-dd]
24. 4-(4-(p-bromophenyl)-4-hydroxypiperidinol)-4'-fluorobutyrophenone Decanoate (ester)
25. Bromperidol Decanoate [ep Impurity]
26. Bromperidol Decanoate [ep Monograph]
27. D02626
28. R 46,541
29. Q27266190
30. 4-(4-(p-bromophenyl)-4-hydroxypiperidinol)-4'-fluorobutyrophenone Decanoate
| Molecular Weight | 574.6 g/mol |
|---|---|
| Molecular Formula | C31H41BrFNO3 |
| XLogP3 | 7.9 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 16 |
| Exact Mass | 573.22538 g/mol |
| Monoisotopic Mass | 573.22538 g/mol |
| Topological Polar Surface Area | 46.6 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 665 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Bromperidol Decanoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bromperidol Decanoate, including repackagers and relabelers. The FDA regulates Bromperidol Decanoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bromperidol Decanoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bromperidol Decanoate supplier is an individual or a company that provides Bromperidol Decanoate active pharmaceutical ingredient (API) or Bromperidol Decanoate finished formulations upon request. The Bromperidol Decanoate suppliers may include Bromperidol Decanoate API manufacturers, exporters, distributors and traders.
click here to find a list of Bromperidol Decanoate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bromperidol Decanoate CEP of the European Pharmacopoeia monograph is often referred to as a Bromperidol Decanoate Certificate of Suitability (COS). The purpose of a Bromperidol Decanoate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Bromperidol Decanoate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Bromperidol Decanoate to their clients by showing that a Bromperidol Decanoate CEP has been issued for it. The manufacturer submits a Bromperidol Decanoate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Bromperidol Decanoate CEP holder for the record. Additionally, the data presented in the Bromperidol Decanoate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Bromperidol Decanoate DMF.
A Bromperidol Decanoate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Bromperidol Decanoate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Bromperidol Decanoate suppliers with CEP (COS) on PharmaCompass.
Bromperidol Decanoate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bromperidol Decanoate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bromperidol Decanoate GMP manufacturer or Bromperidol Decanoate GMP API supplier for your needs.
A Bromperidol Decanoate CoA (Certificate of Analysis) is a formal document that attests to Bromperidol Decanoate's compliance with Bromperidol Decanoate specifications and serves as a tool for batch-level quality control.
Bromperidol Decanoate CoA mostly includes findings from lab analyses of a specific batch. For each Bromperidol Decanoate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bromperidol Decanoate may be tested according to a variety of international standards, such as European Pharmacopoeia (Bromperidol Decanoate EP), Bromperidol Decanoate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bromperidol Decanoate USP).
LOOKING FOR A SUPPLIER?
